Manufacturer record
Saint Michael Biotech: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Saint Michael Biotech (Uttarakhand) were declared Not of Standard Quality between September 2024 and October 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: B22-275, Metronidazole 400 mg Tablets (Metagyl - 400) (exp May 2025). RDTL Guwahati (CDSCO lab) found it not of standard quality: Dissolution of Metronidazole. Listed in the October 2024 alert.
Records by type
2 records linked to Saint Michael Biotech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metronidazole 400 mg Tablets (Metagyl - 400) | Batch B22-275Mfg Dec 2022 · Exp May 2025 | Dissolution of Metronidazole.Dissolution | RDTL GuwahatiCDSCO lab | Oct 2024 |
| Ofloxacin & Ornidazole Tablets I.P. (SMB OZ TABLETS) | Batch B22-114Mfg Aug 2022 · Exp Jul 2025 | Dissolution of Ofloxacin & OrnidazoleDissolution | RDTL GuwahatiCDSCO lab | Sep 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.